TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship January 18, 1980
TCL Archive Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says April 23, 1999